The relationship between bipolar disorder and cannabis use in daily life: An Experience Sampling study

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Tyler, Elizabeth ^a   Jones, Steven ^a   Black, Nancy ^b   Carter, Lesley Anne ^b   Barrowclough, Christine ^b  

^a LANCASTER UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFFECT; ARTICLE; BIPOLAR DISORDER; CANNABIS USE; CLINICAL ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEPRESSION; EXPERIENCE SAMPLING METHOD; FEMALE; HUMAN; MALE; MANIA; METHODOLOGY; MOOD DISORDER; OUTCOME ASSESSMENT; SELF MEDICATION; ADVERSE EFFECTS; CANNABIS SMOKING; PSYCHOLOGY; SELF CONCEPT;

CANNABIS;

ADULT; AFFECT; BIPOLAR DISORDER; FEMALE; HUMANS; MALE; MARIJUANA SMOKING; SAMPLING STUDIES; SELF CONCEPT; SELF MEDICATION;

EID: 84928879678     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118916     Document Type: Article

References (56)

1. Angst J. Comorbidity of mood disorders: a longitudinal prospective study. British Journal of Psychiatry Supplement 1996;30:31-37. PMID: 8864146
2. Strakowski SM, Del Bello MP, Fleck DE, Arndt S. The Impact of Substance Abuse on the Course of Bipolar Disorder. Biological Psychiatry 2000;48:477-485. PMID: 11018221
3. Cassidy F, Ahearn EP, Carroll BJ. Substance abuse in bipolar disorder. Bipolar Disorders 2001;3(4):181-188. PMID: 11552957
4. Brown ES, Suppes T, Adinoff B, Thomas NR. Drug abuse and bipolar disorder: comorbidity or misdiagnosis? Journal of Affective Disorders 2001;65(2):105-115. PMID: 11356233
5. Van Rossum I, Boomsma M, Tenback D, Reed C, Van Os J. Does Cannabis Use Affect Treatment Outcome in Bipolar Disorder? A longitudinal Analysis. The Journal of Nervous and Mental Disease 2009;197(1):35-40.
6. González-Pinto A, Reed C, Novick D, Bertsch J, Haro JM. Assessment of medication adherence in a cohort of patients with bipolar disorder. Pharmacopsychiatry. 2010;43(7):263-70. doi: 10.1055/s-0030-1263169 PMID: 20842617
7. Lev-Ran S, Le Foll B, McKenzie K, George TP, Rehm J. Bipolar disorder and co-occurring cannabis use disorders: characteristics, co-morbidities and clinical correlates. Psychiatry Research. 2013;209(3):459-65 doi: 10.1016/j.psychres.2012.12.014 PMID: 23312479
8. Strakowski SM, Del Bello MP. The Co-occurrence of Bipolar and Substance Use Disorders. Clinical Psychology Review 2000;20(2):191-206. PMID: 10721497
9. Henquet C, Krabbendam L, De Graaf R, Ten Have M, Van Os J. Cannabis use and expression of mania in the general population. Journal of Affective Disorders 2006;95:103-110. PMID: 16793142
10. Van Laar M, Van Dorsselaer S, Monshouwer K De Graaf R. Does cannabis use predict the first incidence of mood and anxiety disorders in the adult population? Addiction 2007;102:1251-1260. PMID: 17624975
11. Tijssen MJA, Van Os J, Wittchen HU, Lieb R, Beesdo K, Wichers M. Risk factors predicting onset and persistence of subthreshold expression of bipolar psychopathology among youth from the community. Acta Psychiatrica Scandinavica 2010;122:255-266. doi: 10.1111/j.1600-0447.2010.01539.x PMID: 20199490
12. Merikangas KR, Herrell R, Swendsen J, Rossler W, Ajdacic-Gross V, Angst J. Specificity of Bipolar Spectrum Conditions in the Comorbidity of Mood and Substance Use Disorders. Archives of General Psychiatry 2008;65(1):47-52. doi: 10.1001/archgenpsychiatry.2007.18 PMID: 18180428
13. Grinspoon L, Bakalar JB. The use of cannabis as a mood stabilizer in bipolar disorder: anecdotal evidence and the need for clinical research. Journal of Psychoactive Drugs 1998;30:171-177. PMID: 9692379
14. Gruber AJ, Pope HG, Brown ME. Do patients use marijuana as an antidepressant? Depression 1996;4:77-80. PMID: 9160645
15. Healey C, Peters S, Kinderman P, McCracken C, Morriss R. Reasons for substance use in dual diagnosis bipolar disorder and substance use disorders: A qualitative study. Journal of Affective Disorders 2009;113(1-2):118-126. doi: 10.1016/j.jad.2008.06.009 PMID: 18684514
16. Ashton CH, Moore PB, Gallagher P, Young AH. Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential. Journal of Psychopharmacology 2005;19(3):293-300. PMID: 15888515
17. Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Archives of General Psychiatry 1997;43:313-321.
18. Weaver T, Maden P, Charles V, Stimson G, Renton A, Tyrer P et al. Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. British Journal of Psychiatry 2003;183:304-13. PMID: 14519608
19. Gregg L, Barrowclough C, Haddock G Reasons for increased substance use in psychosis. Clinical Psychology Review 2007;27(4):494-510. PMID: 17240501
20. Henquet C, Van Os J, Kuepper R, Delespaul P, Smits M, Campo J et al. Psychosis reactivity to cannabis use in daily life: an experience sampling study. The British Journal of Psychiatry 2010;196:447-453. doi: 10.1192/bjp. bp. 109.072249 PMID: 20513854
21. De VriesMWed. The Experience of Psychopathology: Investigating Mental Disorders in their Natural Settings. Cambridge: Cambridge University Press, 1992.
22. Delespaul PAEG. Assessing Schizophrenia in Daily Life. University of Maastricht: Maastricht, 1995.
23. Myin-Germey I, Oorschot M, Collip D, Lataster J, Delespaul PJ, Van Os J. Experience sampling research in psychopathology: opening the black box of daily life Psychological Medicine 2009;39:1533-1547. doi: 10.1017/S0033291708004947 PMID: 19215626
24. Palmier-Claus J, Myin-Germeys I, Barkus E, Bentley L, Uadachina A, Delespaul EG et al. Experience sampling research in individuals with mental illness: reflections and guidance. Acta Psychiatrica Scandinavica 2010;123(1):12-20. doi: 10.1111/j.1600-0447.2010.01596.x PMID: 20712828
25. Bolger N, Davis A, Rafaeli E. Diary methods: capturing life as it is lived, Annual Review of Psychology 2003;54:579-616. PMID: 12499517
26. Havermans R, Nicolson NA, De Vries MW. Daily hassles, uplifts, and time us in individuals with bipolar disorder in remission, The Journal of Nervous and Mental Disease 2007;195(9):745-751. PMID: 17984774
27. Knowles R, Tai S, Jones SH, Highfield J, Morriss R, Bentall RP (2007). Stability of self-esteem in bipolar disorder: Comparison of remitted bipolar patients, remitted unipolar patients and healthy controls. Bipolar Disorders, 2007;9:490-495.
28. First MB, Spitzer RL, Gibbon M, Williams J BW. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I). Arlington, VA: American Psychiatric, 1997.
29. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62. PMID: 14399272
30. Bech P, Rafaelsen OJ, Kramp P, Bolwig TG. The mania rating scale: scale construction and interobserver agreement. Neuropharmacology 1978:17: 430-431.
31. Myin-Germeys I, Van Os J, Schwartz JE, Stone AA, Delespaul PA. Emotional reactivity to daily life stress in psychosis. Archives of General Psychiatry 2001b; 58:1137-1144. PMID: 11735842
32. Myin-Germeys I, Delespaul P, Van Os J. Behavioural sensitization to daily life stress in psychosis. Psychological Medicine 2005;35:733-741. PMID: 15918350
33. Myin-Germeys I, Krabbendam L, Jolles J, Delespaul PA, Van Os J. Are cognitive impairments associated with sensitivity to stress in schizophrenia? An experience sampling study. American Journal of Psychiatry 2002;159:443-449. PMID: 11870009
34. Stata Corp. Stata Statistical Software: Release 11. College Station, TX: StataCorp LP, 2009.
35. Ashton H, Golding JF, Marsh VR, Millman JE, Thompson JW. The seed and the soil: effect of dosage, personality and starting state on the response to α9-tetrahydrocannabinol in man. Br J Clin Pharmacol 1981;12:705-720. PMID: 6277355
36. Ashton H. Cannabis in palliative care. CME Bull Palliat Med 1999a; 1:73-77.
37. Johns A. The psychiatric effects of cannabis. Br J Psychiatry 2001;178:116-122. PMID: 11157424
38. Ashton H. Adverse effects of cannabis and cannabinoids. Br J Anaesth 1999b; 83:637-649. PMID: 10673884
39. Murray RM, Morrison PD, Henquet C, Di Forti M. Cannabis, the mind and society: the hash realities. Nat Rev Neurosci 2007;8:885-95. PMID: 17925811
40. Henquet C, Rosa A, Delespaul P, Papiol S, Fananas L, Van Os J et al. COMT Val (158) Met moderation of cannabis-induced psychosis: a momentary assessment study of ' switching on' hallucinations in the flow of daily life. Acta Psychiatrica Scandinavica 2008;119:156-160. doi: 10.1111/j.1600-0447.2008. 01265.x PMID: 18808401
41. Barkus E, Lewis S. Schizotypy and psychosis-like experiences from recreational cannabis in a nonclinical sample. Psychological Medicine 2008;38(9):1267-76. doi: 10.1017/S0033291707002619 PMID: 18205966
42. Kintz P. Drug Testing in Addicts: A Comparison Between Urine, Sweat, and Hair. Therapeutic Drug Monitoring 1996;18(4):450-455. PMID: 8857567
43. Hardwick S, King L. Home Office Cannabis Potency Study. (http://drugs.homeoffice.gov. uk/publication-search/cannabis/potency). Home Office, 2008.
44. Potter DJ, Clark P, Brown MB. Potency of D9-THC and other cannabinoids in cannabis in England in 2005: implications for psychoactivity and pharmacology. J Forens Sci 2008;53:90-4.
45. Heishman SJ, Arasteh K, Stitzer ML. Comparative effects of alcohol and marijuana on mood, memory and performance. Pharmacol Biochem Behav 1997;58:93-101. PMID: 9264076
46. Varma VK, Malhotra AK, Dang R, Das K, Nehra, R. Cannabis and cognitive functions: a prospective study. Drug and Alcohol Dependence 1988 21(2):147-52. PMID: 3262049
47. Ringen PA, Vaskinn A, Sundet K, Engh JA, Jonsdottir H, Simonsen C, et al. Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia. Psychological. Medicine 2009;40:1337-1347.
48. Harrison LD, Backenheimer M, Inciardi JA. Cannabis use in the United States: Implications for policy 1995). In: Cohen P and Sas A (Eds). Cannabisbeleid in Duitsland, Frankrijk en de Verenigde Staten. Amsterdam, 1996:198-205.
49. Schuckit MA. "Are There Dangers to Marijuana?" In: Inciardi JA and McElrath K (Eds). The American Drug Scene. Los Angeles: Roxbury Publishing Co, 1995.
50. Weiss HM, Nicholas JP, Daus CS. An examination of the joint effects of affective experiences and job beliefs on job satisfaction and variations in affective experiences over time. Organizational Behavior and Human Decision Processes 1999;78:1-24. PMID: 10092469
51. Ilies R, Judge T A. Understanding the dynamic relationships among personality, mood, and job satisfaction: A field experience sampling study. Organizational Behavior and Human Decision Processes 2002;8:1119-1139.
52. Reiger DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL. Co morbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990;264:2511-2518. PMID: 2232018
53. Schmitz JM, Averill P, Sayre S, McCleary P, Moeller FG, Swann A: Cognitive-Behavioral Treatment of Bipolar Disorder and Substance Abuse: A Preliminary Randomized Study. Addictive Disorders and their Treatment 2002;1(1):17-24.
54. Weiss RD, Griffin ML, Greenfield SF, Najavits LM, Wyner D, Soto JA et al. Group therapy for patients with bipolar disorder and substance dependence: results of a pilot study. J Clin Psychiatry 2000;61(5):361-7. PMID: 10847311
55. Weiss MD, Griffin ML et al. A Randomised trial of integrated group therapy versus group drug counselling for patients with bipolar disorder and substance dependence. American Journal of Psychiatry 2007;164:100-107. PMID: 17202550
56. Weiss RD, Griffin ML A "community friendly" version of integrated group therapy for patients with BD and SD: A randomised controlled trail. Drug and alcohol dependence 2009;104:212-219. doi: 10.1016/j.drugalcdep. 2009.04.018 PMID: 19573999